Robert Glazer, PhD, is a Professor in the Departments of Oncology and Pharmacology and has been a Georgetown faculty member for the past 25 years. His primary educational interests are in graduate school teaching where he directs the Cancer Pharmacology course (TBIO536) for the Tumor Biology Training Program. He also lectures in Cell and Molecular Biology (CBIO539) and Cell and Molecular Aspects of the Transformed Cell (TBIO508). He previously taught the unit on Hyperlipidemia Drugs in the Medical Pharmacology course for several years prior to the new integrated curriculum. Dr. Glazer has published more than 200 papers in the areas of cancer pharmacology and tumor and molecular biology, and currently studies the role of nuclear receptors and the tumor microenvironment in transgenic breast cancer animal models.